These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
251 related items for PubMed ID: 7869768
61. Role of PML in cell growth and the retinoic acid pathway. Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C, Grosveld F, Pandolfi PP. Science; 1998 Mar 06; 279(5356):1547-51. PubMed ID: 9488655 [Abstract] [Full Text] [Related]
62. Modulation of p53, WAF1/p21 and BCL-2 expression during retinoic acid-induced differentiation of NB4 promyelocytic cells. Bocchia M, Xu Q, Wesley U, Xu Y, Korontsvit T, Loganzo F, Albino AP, Scheinberg DA. Leuk Res; 1997 May 06; 21(5):439-47. PubMed ID: 9225073 [Abstract] [Full Text] [Related]
63. Establishment of a human acute promyelocytic leukemia-ascites model in SCID mice. Zhang SY, Zhu J, Chen GQ, Du XX, Lu LJ, Zhang Z, Zhong HJ, Chen HR, Wang ZY, Berger R, Lanotte M, Waxman S, Chen Z, Chen SJ. Blood; 1996 Apr 15; 87(8):3404-9. PubMed ID: 8605358 [Abstract] [Full Text] [Related]
70. [Effect of APN/CD13 on bestatin enhancing all-trans-retinoic acid-inducing differentiation in NB4 cells]. Qian XJ, Lin MF. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct 15; 19(5):1125-8. PubMed ID: 22040956 [Abstract] [Full Text] [Related]
71. Promyelocytic leukemia-nuclear body formation is an early event leading to retinoic acid-induced differentiation of neuroblastoma cells. Delaune A, Corbière C, Benjelloun FD, Legrand E, Vannier JP, Ripoll C, Vasse M. J Neurochem; 2008 Jan 15; 104(1):89-99. PubMed ID: 17986232 [Abstract] [Full Text] [Related]
72. Chemically induced isomerization and differential uptake modulate retinoic acid disposition in HL-60 cells. Lanvers C, Hempel G, Blaschke G, Boos J. FASEB J; 1998 Dec 15; 12(15):1627-33. PubMed ID: 9837852 [Abstract] [Full Text] [Related]
73. All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. Chomienne C, Ballerini P, Balitrand N, Daniel MT, Fenaux P, Castaigne S, Degos L. Blood; 1990 Nov 01; 76(9):1710-7. PubMed ID: 2224120 [Abstract] [Full Text] [Related]
74. [Molecular basis of arsenic action in promyelocytic leukemia cells]. Wysocki R, Wiśniewska E. Postepy Biochem; 2002 Nov 01; 48(2):121-30. PubMed ID: 12362602 [No Abstract] [Full Text] [Related]
75. Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line. Ruchaud S, Duprez E, Gendron MC, Houge G, Genieser HG, Jastorff B, Doskeland SO, Lanotte M. Proc Natl Acad Sci U S A; 1994 Aug 30; 91(18):8428-32. PubMed ID: 7915840 [Abstract] [Full Text] [Related]
77. All trans retinoic acid induces apoptosis in acute promyelocytic NB4 cells when combined with isoquinolinediol, a poly(ADP-ribose) polymerase inhibitor. Berry DM, Williams K, Meckling-Gill KA. Leuk Res; 2000 Apr 30; 24(4):307-16. PubMed ID: 10713328 [Abstract] [Full Text] [Related]
78. Retinoic acid induced HL-60 myeloid differentiation: dependence of early and late events on isomeric structure. Yen A, Powers V, Fishbaugh J. Leuk Res; 1986 Apr 30; 10(6):619-29. PubMed ID: 3458975 [Abstract] [Full Text] [Related]
80. Retinoic acid attenuates promyelocytic leukemia protein-induced cell death in breast cancer cells by activation of the ubiquitin-proteasome pathway. Son SH, Yu E, Ahn Y, Choi EK, Lee H, Choi J. Cancer Lett; 2007 Mar 18; 247(2):213-23. PubMed ID: 16740359 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]